相关临床试验
142
17 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1958
进行中（未招募）
8
5.6%
已完成
80
56.3%
Enrolling By Invitation
3
2.1%
尚未招募
6
4.2%
招募中
16
11.3%
暂停
2
1.4%
终止
8
5.6%
Unknown
19
13.4%
暂无批准数据
- A University of Oulu study of 2,264 participants from the Northern Finland Birth Cohort 1966 found higher habitual coffee intake associated with lower total and visceral fat and greater skeletal muscle mass. - Higher coffee consumption correlated with lower circulating branched-chain amino acids, biomarkers linked to insulin resistance and type 2 diabetes risk. - The strongest sex-specific associations appeared in men, including a more favorable glucose-insulin profile and higher total and bioavailable testosterone. - As an observational study, the findings demonstrate associations rather than causation, providing a foundation for future mechanistic and intervention research.
- Finnish healthcare system has reduced multiple sclerosis diagnosis time from ten to five months, enabling earlier treatment initiation and improved patient outcomes. - Treatment protocols have shifted dramatically, with highly effective immunomodulating medications now being prescribed as first-line therapy instead of traditional moderate-efficacy drugs. - Despite COVID-19 pandemic challenges, Finland maintained consistent MS diagnosis and treatment timelines, demonstrating resilient healthcare delivery.
